Johnson & Johnson: Migraine Disorders trials
The registry lists 26 Migraine Disorders studies with Johnson & Johnson as lead sponsor. 1 are open to participants now and 3 have results posted.
Phase 1 2Phase 2 3Phase 3 12Phase 4 4No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- MMA Embolization for Refractory Chronic MigraineRecruitingNCT06735833Not applicable
- Continuous Treatment Study of Topiramate in Migraine ParticipantsCompletedNCT01799590Phase 2Results posted
- A Dose-Finding Study of Topiramate (JNS019) in Participants With MigraineCompletedNCT01081795Phase 2Results posted
- An Efficacy and Tolerability Study of Topiramate in Participants With MigraineCompletedNCT01060111Phase 4Results posted
- Occipital Nerve Stimulation in the Treatment of MigraineTerminatedNCT01855672Phase 1
- A Study of Prophylaxis for Migraine Patients With Topiramate in IndiaCompletedNCT01836874
- The Coherex FlatStent™ EF PFO Migraine RegistryTerminatedNCT01280578
- A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or SeparatelyCompletedNCT00752466Phase 1
- Study on Migraine and Headache in Epileptic PatientsCompletedNCT00642564
- A Study Comparing the Effectiveness and Safety of ULTRACET® (Tramadol HCl/Acetaminophen) Versus Placebo for the Treatment of Acute Pain From a Migraine HeadacheCompletedNCT00297375Phase 4
- An Observational Study Evaluating the Safety of Topiramate for the Prevention of MigraineCompletedNCT00297336
- An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With TriptansCompletedNCT00261469Phase 2
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of MigraineCompletedNCT00253175Phase 3
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in ChildrenCompletedNCT00237302Phase 3
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCompletedNCT00236561Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00236509Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00231595Phase 3
- The Prolonged Use of Topiramate for Preventing Migraine HeadachesCompletedNCT00216619Phase 3
- The Effectiveness and Safety of Topiramate on Prevention of Chronic MigraineCompletedNCT00216606Phase 3
- The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine PainCompletedNCT00212823Phase 4
- Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
- A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine HeadachesCompletedNCT00210912Phase 3
- An Open Label Extension of a Study of Topiramate in Chronic Migraine.CompletedNCT00210873Phase 3
- An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.CompletedNCT00210860Phase 3
- Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine HeadachesCompletedNCT00210821Phase 3
- A Study of the Effectiveness and Safety of Topiramate for the Prevention of Migraine Attacks in ChildrenCompletedNCT00210535Phase 3